Outcomes of Cognitively Impaired Not Demented at 2 Years in the Canadian Cohort Study of Cognitive Impairment and Related Dementias

Background: People who are cognitively impaired not demented (CIND) can be at an increased risk for developing dementia, but little is known about the natural history of CIND in clinical settings. Method: We examined the 2-year outcome of CIND subjects in the Canadian Cohort Study of Cognitive Impairment and Related Dementias.CIND was diagnosed when at least one positive item was endorsed on the DSM-III-R dementia criteria, but not all criteria were met. CIND was further subclassified as: pre-Alzheimer’s disease (pre-AD), vascular cognitive impairment (VCI-ND), non-AD degenerative, psychiatric, other neurologic, other medical conditions, mixed disorders and no etiology identified (not otherwise specified [NOS]). Result: Of 146 CIND patients with 2-year follow-up data available, 49 (34%) progressed to dementia, while 20 (14%) recovered to not cognitively impaired (NCI). Progressors were significantly older than stable CIND and reverters (p < 0.0001; mean age = 71.1, 64.3, and 59.1, respectively), and there were significantly (p = 0.001) more ApoE Ε4 carriers among progressors (67%) than stable CIND (29%) and reverters (12%). Pre-AD CIND and VCI-ND had the highest rate of conversion to dementia (41.0 and 40.0%, respectively), while psychiatric CIND and CIND NOS had highest rate of recovery to NCI (20.0 and 30.0%, respectively). All conversions in pre-AD CIND were to ‘probable AD’. Conclusion: CIND consists of a heterogeneous group of disorders that can be classified syndromically. Many subclassess – not just those with pre-AD CIND – are at high risk of progression to dementia, usually to Alzheimer’s disease.

[1]  M P Lawton,et al.  Validation of the Cumulative Illness Rating Scale in a Geriatric Residential Population , 1995, Journal of the American Geriatrics Society.

[2]  R Levy,et al.  Aging-associated cognitive decline. Working Party of the International Psychogeriatric Association in collaboration with the World Health Organization. , 1994, International psychogeriatrics.

[3]  H. Feldman,et al.  Apolipoprotein E ε4 genotype as a risk factor for cognitive decline and dementia: data from the Canadian Study of Health and Aging , 2004, Canadian Medical Association Journal.

[4]  E. Tangalos,et al.  Mild Cognitive Impairment Clinical Characterization and Outcome , 1999 .

[5]  D. Hogan,et al.  Predicting Who Will Develop Dementia in a Cohort of Canadian Seniors , 2000, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.

[6]  E. Reiman,et al.  Vascular risk factors, incidence of MCI, and rates of progression to dementia , 2004, Neurology.

[7]  C. Derouesné.  [Mini-mental state examination]. , 2001, Revue neurologique.

[8]  Canadian study of health and aging: study methods and prevalence of dementia. , 1994, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.

[9]  R. Petersen.  Mild cognitive impairment as a diagnostic entity , 2004, Journal of internal medicine.

[10]  H. Tuokko,et al.  Five-year follow-up of cognitive impairment with no dementia. , 2003, Archives of neurology.

[11]  Janice E Graham,et al.  Prevalence and severity of cognitive impairment with and without dementia in an elderly population , 1997, The Lancet.

[12]  B. Linn,et al.  CUMULATIVE ILLNESS RATING SCALE , 1968, Journal of the American Geriatrics Society.

[13]  Clinical and neuropathological criteria for frontotemporal dementia. The Lund and Manchester Groups. , 1994, Journal of neurology, neurosurgery, and psychiatry.

[14]  S. Ferris,et al.  Age‐associated memory impairment: Proposed diagnostic criteria and measures of clinical change — report of a national institute of mental health work group , 1986 .

[15]  S. Gauthier,et al.  Development of a functional measure for persons with Alzheimer's disease: the disability assessment for dementia. , 1999, The American journal of occupational therapy : official publication of the American Occupational Therapy Association.

[16]  A. L. Rue,et al.  Criteria for diagnosing age‐associated memory impairment: Proposed improvements from the field , 1989 .

[17]  A. Levy,et al.  A Canadian Cohort Study of Cognitive Impairment and Related Dementias (ACCORD): Study Methods and Baseline Results , 2003, Neuroepidemiology.

[18]  J. Dickens,et al.  Prevalence of cognitive impairment: Data from the Indianapolis Study of Health and Aging , 2001 .

[19]  K. Kosaka,et al.  Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB) , 1996, Neurology.

[20]  J. Morris,et al.  Current concepts in mild cognitive impairment. , 2001, Archives of neurology.

[21]  R. Lévy,et al.  Aging-Associated Cognitive Decline , 1994, International Psychogeriatrics.

[22]  H. Tuokko,et al.  The Assessment of Everyday Functioning Using the Present Functioning Questionnaire and the Functional Rating Scale in Elderly Samples , 1989 .

[23]  H. Amièva,et al.  Incidence and outcome of mild cognitive impairment in a population-based prospective cohort , 2002, Neurology.

[24]  Kenneth Rockwood,et al.  Variations in case definition affect prevalence but not outcomes of mild cognitive impairment , 2003, Neurology.

[25]  H. Feldman,et al.  The Consortium to Investigate Vascular Impairment of Cognition: Methods and First Findings , 2003, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.